Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Barbui

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Epidemiology and Psychiatric Sciences|January 20, 2017
Evidence, knowledge, implementation: glossary of terminologyC Barbui
The American Journal of Psychiatry|January 20, 1998
Olanzapine on trialC Barbui
Epidemiology and Psychiatric Sciences|March 20, 2015
Access and use of psychotropic medicines in low-resource settingsC Barbui
Epidemiology and Psychiatric Sciences|September 8, 2015
Clinical use of the diagnostic criteria for major depressive disorderC Barbui
Pharmacoepidemiology and Drug Safety|May 1, 2002
Drug epidemiology in Italy: methods and ethical issues. The example of psychiatryC Barbui
Acta Psychiatrica Scandinavica|December 1, 2000
Italy's mad lawC Barbui
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 9, 2005
Evidence-based medicine and medicine-based evidenceC Barbui
Epidemiology and Psychiatric Sciences|November 3, 2015
Improving access to medicines for mental disorders in low-resource settings: some achievements but still a long road aheadC Barbui, S Chattherjee
Epidemiology and Psychiatric Sciences|January 12, 2016
Social and environmental adversities, neurobiological processes and mental disordersC Barbui, B Saraceno
International Clinical Psychopharmacology|April 29, 1999
Clinical trials of new antipsychotics: a critical appraisalC Barbui, S Garattini
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Epidemiology and Psychiatric Sciences|January 20, 2017
Evidence, knowledge, implementation: glossary of terminologyC Barbui
The American Journal of Psychiatry|January 20, 1998
Olanzapine on trialC Barbui
Epidemiology and Psychiatric Sciences|March 20, 2015
Access and use of psychotropic medicines in low-resource settingsC Barbui
Epidemiology and Psychiatric Sciences|September 8, 2015
Clinical use of the diagnostic criteria for major depressive disorderC Barbui
Pharmacoepidemiology and Drug Safety|May 1, 2002
Drug epidemiology in Italy: methods and ethical issues. The example of psychiatryC Barbui
Acta Psychiatrica Scandinavica|December 1, 2000
Italy's mad lawC Barbui
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 9, 2005
Evidence-based medicine and medicine-based evidenceC Barbui
Epidemiology and Psychiatric Sciences|November 3, 2015
Improving access to medicines for mental disorders in low-resource settings: some achievements but still a long road aheadC Barbui, S Chattherjee
Epidemiology and Psychiatric Sciences|January 12, 2016
Social and environmental adversities, neurobiological processes and mental disordersC Barbui, B Saraceno
International Clinical Psychopharmacology|April 29, 1999
Clinical trials of new antipsychotics: a critical appraisalC Barbui, S Garattini
Pageof 11